We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$405M
AUM Growth
+$39.5M
Cap. Flow
-$2.61M
Cap. Flow %
-0.64%
Top 10 Hldgs %
94.87%
Holding
24
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
IOT icon
Samsara
IOT
+$31.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 43.66%
2 Technology 36.06%
3 Financials 10.77%
4 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DICE
1
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$78.8M 19.47%
2,748,970
– –
PATH icon
2
UiPath
PATH
$8.3B
$67M 16.56%
3,816,569
– –
IOT icon
3
Samsara
IOT
$23.2B
$45.3M 11.18%
2,294,776
+1,962,256
+590% +$31.1M
NU icon
4
Nu Holdings
NU
$73.6B
$43.6M 10.77%
9,156,347
– –
DASH icon
5
DoorDash
DASH
$94B
$38.4M 9.48%
603,512
– –
SNOW icon
6
Snowflake
SNOW
$114B
$33.3M 8.22%
215,535
– –
TXG icon
7
10x Genomics
TXG
$7.31B
$26.9M 6.64%
481,770
– –
ACRV icon
8
Acrivon Therapeutics
ACRV
$83.6M
$21M 5.18%
1,652,605
– –
OLK
9
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$15.9M 3.93%
705,514
– –
ABOS icon
10
Acumen Pharmaceuticals
ABOS
$193M
$13.9M 3.43%
3,417,075
– –
KRTX
11
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$10.7M 2.64%
58,895
– –
TARS icon
12
Tarsus Pharmaceuticals
TARS
$3.04B
$3.27M 0.81%
260,000
– –
MASS icon
13
908 Devices
MASS
$414M
$2.81M 0.69%
326,427
– –
SPRB
14
Spruce Biosciences
SPRB
$151M
$1.74M 0.43%
10,493
– –
CADL icon
15
Candel Therapeutics
CADL
$897M
$1.1M 0.27%
811,737
– –
TSHA icon
16
Taysha Gene Therapies
TSHA
$1.94B
$580K 0.14%
724,873
– –
CRWD icon
17
CrowdStrike
CRWD
$221B
$119K 0.03%
3,456
– –
CPNG icon
18
Coupang
CPNG
$29B
$112K 0.03%
6,971
– –
ABSI icon
19
Absci
ABSI
$1.58B
$101K 0.03%
57,804
– –
DDOG icon
20
Datadog
DDOG
$91.7B
$99.3K 0.02%
1,366
– –
TOST icon
21
Toast
TOST
$20.1B
$79.8K 0.02%
4,494
– –
CFLT
22
DELISTED
Confluent
CFLT
$32.6K 0.01%
1,354
– –
GTLB icon
23
GitLab
GTLB
$7.2B
$22.6K 0.01%
658
– –

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q1 2023 Portfolio in Review

As of Q1 2023, Sands Capital Ventures held 24 positions worth $405M, up 11% from $365M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Sands Capital Ventures opened no new positions and exited 1, leaving the 24-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 49% a quarter earlier, followed by Technology and Financials.

  • Sands Capital Ventures added most to Samsara in Q1 2023, an estimated $31.1M increase.
  • Sands Capital Ventures's ten largest holdings make up 95% of its $405M portfolio in Q1 2023.
  • Sands Capital Ventures opened 0 new positions and closed 1 in Q1 2023.
  • Sands Capital Ventures's portfolio value rose 11% quarter-over-quarter to $405M.

Based on Sands Capital Ventures's 13F filing for Q1 2023, filed 12 May 2023.